天域生物科技股份有限公司关于取消监事会、调整董事会人数、不设副董事长并修订《公司章程》及部分治理制度的公告

Core Points - Tianyu Biotechnology Co., Ltd. has announced the cancellation of its supervisory board and adjustments to its board of directors, including a reduction in the number of directors and the elimination of the vice chairman position [1][3] - The company will revise its articles of association and related governance systems to reflect these changes [1][4] Group 1: Cancellation of Supervisory Board - The supervisory board will be abolished, and its functions will be transferred to the audit committee of the board of directors, ensuring that the internal supervision mechanism remains operational [1] - The rules governing the supervisory board will be abolished, and any references to the supervisory board in the company's regulations will no longer apply [2] Group 2: Adjustment of Board of Directors - The number of directors on the board will be reduced from 9 to 7, with non-independent directors decreasing from 6 to 4, while the number of independent directors will remain at 3 [3] - The position of vice chairman will no longer be established [3] Group 3: Revision of Articles of Association - The company will amend certain provisions in its articles of association to align with the cancellation of the supervisory board and the adjustments to the board of directors [4]